Researchers followed four patients who had spinal cord injuries for five years, and two of them showed “durable evidence of neurological improvement” after treatment with the stem cell implantation, according to a Dec. 17 feature from the university. All four patients tolerated the treatments well, the study found.
With these results, researchers plan to initiate phase 2 of the trial.
The findings were published in the Dec. 17 edition of Cell Reports Medicine.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
